Markus Meyer is a Cardiology physician affiliated with University of Minnesota. OpenAlex indexes 339 publications with 16,970 citations (h-index 55); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2450 Riverside Ave
Minneapolis, MN 554541450
Telephone
612-672-6000Registry record last updated 13 Aug 2019.
Clinical trials
- PACE Cognition Proof-of-Concept Study
Sponsor: University of Minnesota
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202559 payments$274,113openpaymentsdata.cms.gov ↗
- Boston Scientific CorporationProgram year20251 payment
- Medtronic, Inc.Program year202413 payments$105,143openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.4%Statin19.1%Atorvastatin Calcium81%Rosuvastatin Calcium19%Part D<11 patientsAldosterone antagonist (MRA)18.5%Spironolactone100%Part D≥37 patients+ 6 more classes in this area
Metabolism & gastrointestinal
9.2%SGLT2 inhibitor6.8%Jardiance100%Part D≥13 patientsPotassium supplement2.4%Potassium Chloride100%Part D<11 patientsBlood & clotting
6.4%Phosphodiesterase 3 Inhibitor3.5%Cilostazol100%Part D<11 patientsFactor Xa inhibitor2.9%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Body mass index and outcome in patients with COVID-19: A dose–response meta-analysis
Diabetes & Metabolism
2020 - Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy?
Internal and Emergency Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Maria Hordinsky, MD
University of Minnesota
Paul Tuite, MD
University of Minnesota
Paul Bigliardi
University of Minnesota
George Goding, MD
University of Minnesota
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”